Chungcheongbuk-do, South Korea

Sungsoon Kim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sungsoon Kim in MERS-CoV Research

Introduction

Sungsoon Kim is an accomplished inventor based in Chungcheongbuk-do, South Korea. He is best known for his significant contributions to the field of virology, particularly in addressing the challenges posed by the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). His groundbreaking work has culminated in the development of a patented technology that holds promise for therapeutic and diagnostic applications.

Latest Patents

Sungsoon Kim holds a patent titled "Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof". This invention focuses on monoclonal antibodies aimed at the spike protein of MERS-CoV. The antibodies, designated as 77-A5, 77-A6, 90-A3, 90-A9, 90-B2, 90-B7, 90-C4, 90-E5, 90-E6, 90-F1, and 90-F2, demonstrate remarkable attachment strength to both the full-length spike protein and its S1 domain. Notably, certain antibodies exhibit neutralizing capabilities against MERS-CoV, showcasing potential for future therapeutic interventions.

Career Highlights

Sungsoon Kim's career includes significant collaboration with prominent organizations. He has worked with the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, and the Korea Center for Disease Control and Prevention. His engagement with these institutions underscores his commitment to advancing public health through innovative science.

Collaborations

Throughout his career, Sungsoon Kim has collaborated with talented professionals, including Hansaem Lee and Janghoon Choi. These collaborations have contributed to the successful development and validation of his patented technologies.

Conclusion

Sungsoon Kim's innovative work in developing monoclonal antibodies targeting MERS-CoV marks a significant advancement in virology. His patent not only showcases his dedication to scientific research but also holds the potential to improve diagnosis and treatment options for MERS. As the world continues to address viral threats, the contributions of inventors like Sungsoon Kim play a crucial role in protecting public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…